The plant in the Santiago region will be able to fill and finish some 50 million doses annually, and should be ready before 2023 Chinese pharmaceutical Sinovac Biotech Ltd which makes one of the ...

Washington, D.C. – The U.S. Defense Department admitted it spread propaganda in the Philippines aimed at disparaging China’s ...

BEIJING, January 16, 2025--(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ:SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that the ...

Sinovac, one of China’s largest vaccine manufacturers, began Phase III clinical trials in July 2020 in Brazil, expanding the clinical trials to Indonesia, Turkey, and the Philippines by April 2021.

据SINOVAC科兴官微消息，2025年1月2日，由科兴控股生物技术有限公司旗下科兴（大连）疫苗技术有限公司自主研发的水痘减毒活疫苗成功获得澳门药物 ...

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. Major institutions are defined as firms or individuals that exercise ...

A SINOVAC foi a primeira empresa a receber a aprovação de sua vacina contra a gripe H1N1, batizada de Panflu.1 ®, fornecida na campanha de vacinação e no programa de armazenamento do governo ...

Sinovac Biotech (SVA) announced that the Judicial Committee of the Privy Council in London, England, has ruled that the slate of nominees proposed by a group of shareholders at the 2018 Annual ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

BEIJING — Sinovac Biotech Ltd. (NASDAQ:SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that the Judicial Committee of the Privy Council in ...